Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 510Genitourinary 289Other hematologic neoplasm 163Plasma cell 67Myeloid 19Sarcoma 17Dermatologic 16Thoracic 10Tumor-Agnostic 8Breast 7Gynecologic 6Gastrointestinal 6CNS 6Other solid neoplasm 2Classical hematology 2Other neoplasm 1Head & Neck 1Endocrine 1

Conditions

Pituitary Neoplasms 1Craniopharyngioma 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prednisone × Endocrine × Clear all
NCT02190994 2014-07-15

Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions

West China Hospital

Phase 4 Unknown
100 enrolled
CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡